Neuroscience

Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions

TIME Best Inventions honors extraordinary innovations changing lives DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader…

3 months ago

Glytec and Parkview Health Expand Diabetes and Glycemic Management Partnership Across Indiana and Ohio

Renewal of 10 facilities, Emergency Department implementation, and two new hospital expansions position Parkview for CMS readiness BOSTON, Oct. 9,…

3 months ago

Hemostemix Files for Ethics Approval of its Study of Vascular Dementia

Calgary, Alberta--(Newsfile Corp. - October 9, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is…

3 months ago

Hemostemix Files for Ethics Approval of its Study of Vascular Dementia

Calgary, Alberta--(Newsfile Corp. - October 9, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is…

3 months ago

Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease

Event to be held October 14th at 4 p.m. ESTBETHESDA, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc.…

3 months ago

Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era…

3 months ago

An Era Where Meditation Becomes a Quantifiable Achievement — Japan’s First “Quantified Meditation Challenge”

TOKYO, Oct. 7, 2025 /PRNewswire/ -- Meditation entered a new era as the World Meditation League (WML), and All Here…

3 months ago

Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how biomarkers and digital tools are improving clinical trials in neurodegenerative diseases. Attendees will understand the…

3 months ago

Albert Einstein College of Medicine Awarded $18 Million NIH Grant to Improve Treatment for Serious Mental Illness

New Predictive Platform Will Use Digital Technology and AI to Assist Clinician Decision-Making BRONX, N.Y., Oct. 6, 2025 /PRNewswire/ -- Serious…

3 months ago

Clario and the University of Oxford’s NeuroMetrology Lab Advance Parkinson’s Disease Research with the Opal® Wearable Sensor System

Clario partners with the University of Oxford's NeuroMetrology Lab to transform Parkinson's disease research with the Opal® wearable sensor system. Partnership…

3 months ago